1. Home
  2. ATAI vs NML Comparison

ATAI vs NML Comparison

Compare ATAI & NML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • NML
  • Stock Information
  • Founded
  • ATAI 2018
  • NML 2012
  • Country
  • ATAI Germany
  • NML United States
  • Employees
  • ATAI N/A
  • NML N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • NML Finance/Investors Services
  • Sector
  • ATAI Health Care
  • NML Finance
  • Exchange
  • ATAI Nasdaq
  • NML Nasdaq
  • Market Cap
  • ATAI 444.7M
  • NML 487.3M
  • IPO Year
  • ATAI 2021
  • NML N/A
  • Fundamental
  • Price
  • ATAI $3.48
  • NML $8.73
  • Analyst Decision
  • ATAI Strong Buy
  • NML
  • Analyst Count
  • ATAI 3
  • NML 0
  • Target Price
  • ATAI $11.67
  • NML N/A
  • AVG Volume (30 Days)
  • ATAI 8.9M
  • NML 219.3K
  • Earning Date
  • ATAI 08-12-2025
  • NML 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • NML 9.75%
  • EPS Growth
  • ATAI N/A
  • NML N/A
  • EPS
  • ATAI N/A
  • NML N/A
  • Revenue
  • ATAI $1,863,000.00
  • NML N/A
  • Revenue This Year
  • ATAI $423.05
  • NML N/A
  • Revenue Next Year
  • ATAI N/A
  • NML N/A
  • P/E Ratio
  • ATAI N/A
  • NML N/A
  • Revenue Growth
  • ATAI 572.56
  • NML N/A
  • 52 Week Low
  • ATAI $1.03
  • NML $6.09
  • 52 Week High
  • ATAI $4.00
  • NML $7.33
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 60.69
  • NML 47.53
  • Support Level
  • ATAI $3.06
  • NML $8.48
  • Resistance Level
  • ATAI $3.70
  • NML $8.65
  • Average True Range (ATR)
  • ATAI 0.27
  • NML 0.12
  • MACD
  • ATAI 0.00
  • NML -0.01
  • Stochastic Oscillator
  • ATAI 52.46
  • NML 48.65

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.

Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.

Share on Social Networks: